This study focuses on patients who have visible blood in their urine, which may be an early sign of bladder cancer. The purpose of the study is to determine whether an investigational laboratory test can detect bladder cancer in urine. To evaluate the test’s effectiveness, researchers will collect a sample of the participant’s urine, bladder tissue collected during a routine procedure (if available), and information from medical records.
Financial disclosure: Charles Rosser, MD, the person responsible for the conduct of this study, has a personal interest in the investigational test that is being used; he holds intellectual property rights for the test.
What is the full name of this clinical trial?
IIT2019-04-ROSSER-GH: A Novel Multiplex ELISA Assay for Evaluating Patient with gross hematuria for bladder cancer